US stock futures dip as Trump’s firing of Cook sparks Fed independence fears
CTT Pharmaceutical (TADAWUL:2070) Holdings, Inc. (OTCMKTS:CTTH) CEO, Ryan Khouri, reported purchasing 16,100 shares of company stock on June 23, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were bought at a price of $0.025, for a total transaction value of $402. The purchase comes as the stock trades near its 52-week low of $0.02, having declined about 49% year-to-date. With a current market capitalization of $1.66 million, InvestingPro data shows the stock trading at a notably low Price/Book multiple.
Following the transaction, Khouri directly owns 6,903,456 shares of CTT Pharmaceutical Holdings, Inc. InvestingPro analysis reveals 8 additional key insights about CTTH's financial health and market position, available to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.